ResBiotic Pharma, founded by Dr. Vivek Lal, focuses on developing live biotherapeutics (LBPs) to treat chronic lung diseases. The company's core mission is to harness the power of microbiome research to create breakthrough medicines that address chronic health issues. Their product line includes physician-developed supplements aimed at restoring gut health and supporting lung function, leveraging rigorous scientific analysis and testing.
Notable figures affiliated with ResBiotic include Dr. Vivek Lal, a double board-certified physician-scientist renowned for his expertise in microbiome research. The company has achieved significant milestones in the development of scientifically proven prebiotics and probiotics, contributing to both chronic disease management and proactive wellness. ResBiotic's impact is marked by its innovative approach to biotherapeutics, offering new hope for patients with chronic lung conditions.
